Abbott Laboratories ABT
NYSE ABT
$105.71 +0.19 (+0.18%)
As of: Sep 9, 2026 · 1:29 PM EDT

Abbott Laboratories (ABT) Total Debt Growth (5y) (2014 - 2026)

Analysis

Abbott Laboratories (ABT) Total Debt Growth (5y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.84 Bn 178.24 Bn 7.27 Bn
2 Intuitive Surgical 124.46 Bn 119.24 Bn 1.96 Bn
3 Medtronic 118.36 Bn 109.54 Bn 6.34 Bn
4 Stryker 105.10 Bn 101.62 Bn 4.50 Bn
5 Boston Scientific 66.60 Bn 66.06 Bn 3.85 Bn
6 Edwards Lifesciences 49.72 Bn 45.47 Bn 1.35 Bn
7 Alcon 33.92 Bn 32.46 Bn 1.68 Bn
8 Dexcom 32.31 Bn 30.36 Bn 830.00 Mn
9 Steris 21.10 Bn 20.62 Bn 684.20 Mn
10 Zimmer Biomet Holdings 18.14 Bn 17.73 Bn 1.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.00%
Mar 31, 2026 13.04%
Dec 31, 2025 -7.36%
Sep 30, 2025 -7.16%
Jun 30, 2025 -7.35%
Mar 31, 2025 -6.24%
Dec 31, 2024 -2.94%
Sep 30, 2024 -4.74%
Jun 30, 2024 -5.32%
Mar 31, 2024 -5.39%
Dec 31, 2023 -4.42%
Sep 30, 2023 -8.00%
Jun 30, 2023 -4.01%
Mar 31, 2023 -5.04%
Dec 31, 2022 -7.39%
Sep 30, 2022 -7.34%
Jun 30, 2022 -7.12%
Mar 31, 2022 -6.70%
Dec 31, 2021 -4.22%
Sep 30, 2021 10.76%